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ABSTRACT 
Introduction: Robotic-assisted laparoscopic hysterectomy (RALH) for benign uterine conditions has been on the 
rise in the U.S. since the da Vinci system received regulatory clearance in 2005.  There are currently no uniform 
standards for determining operating privileges with the device, and requirements vary by hospital.  The present 
study examines how inpatient complications relate to hospital characteristics for robotic and non-robotic 
laparoscopic hysterectomies, using the largest public source of all-payer inpatient data in the U.S. 
Methods: All patients undergoing laparoscopic hysterectomy for benign neoplasm of the uterus were selected from 
the 2009-2011 Nationwide Inpatient Sample (NIS) core files.  Patient and hospital characteristics were assessed for 
robotic and non-robotic procedures.  Hospitals with complication rates in the top quartile were compared to hospitals 
with complication rates below the 75th percentile.  Results were analyzed by chi-square and Fisher's exact tests in 
SAS 9.3 (SAS Institute, Inc., Cary, NC). 
Results: During the three year period, 5,079 women received robotic assisted laparoscopic hysterectomy for uterine 
fibroids while 13,587 underwent conventional laparoscopic hysterectomy.  After restricting analysis to hospitals 
with 5 or more procedures, the 75th percentile for hospital complication rate was 12.5% for RALH (n=226 
hospitals) and 11.1% for non-robotic procedures (n=633 hospitals).  For RALH, there was a significant association 
between location (urban/rural) and complication rate, with more rural hospitals than expected falling into the higher 
complication group (chi-square = 7.99, p < 0.01).  For non-robotic procedures, there was a significant association 
between teaching status and complication rate, with more teaching hospitals than expected falling into the high 
complication rate group (chi-square = 8.34, p < 0.01). 
Conclusion: This is the first study that we are aware of that examines hospital characteristics as they relate to 
complication rates for RALH.  Data were analyzed without exploring patient characteristics that could relate to 
hospital selection as well as patient outcome.  This study offers tentative evidence that hospital complication rate 
could be related to rural location and/or positive teaching status, leaving the question open for further investigation 
with a controlled analysis. 
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FOREWORD 
 The present manuscript is a Master’s paper for the Public Health Leadership Program 
(PHLP) at UNC Gillings School of Global Public Health.   When I first arrived at Gillings, like 
any student, I was unaware of what the coming years would bring.  I approached the situation 
with a steady openness that allowed me to explore my interests in an interdisciplinary way.  This 
led me to become involved with a variety of students and professionals from outside of my 
program.   
One challenge that I constantly faced was explaining to others what the Public Health 
Leadership Program is and is about.  How can I succinctly describe the unique challenges faced 
by public health professionals and how they necessitate an adaptive leadership strategy?   
I quickly realized that simply being in the program represents a certain privilege, a 
certain knowledge that places one in a leadership role.  Wherever I go, chances are I will be the 
only person in the room with an understanding of two key things: 1) My own leadership style 
and motivations (MBTI, FIRO-B, etc.) and how they interact with others’ leadership styles and 
motivations, and 2) Adaptive leadership problems versus technical leadership problems 
(Fernandez & Steffen).   
I spent the past year involved in medical device research at the U.S. Food and Drug 
Administration (FDA) where I couldn’t help but notice that many of the regulatory agency’s 
challenges are adaptive.  When to take action and which action to take is not always immediately 
clear or comfortable.  Solutions require an interdisciplinary dialogue, learning on the part of all 
parties, the creation of something new, and paradigm shifts (Fernandez & Steffen). 
Many paradigm shifts are happening in the world of medical devices: regulation of 
mobile phone applications, unique device identification (UDI), naloxone auto-injectors, or even 
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surgeons operating remotely from consoles.  Building new capabilities in post-market 
surveillance of medical devices is also an adaptive challenge.  Part of this is learning to leverage 
novel types of data that not all people are familiar with yet.   
Increasingly complex technology in both the devices themselves and the technology we 
use to assess them poses far reaching implications for patients and providers as well as adaptive 
leadership challenges to researchers and regulators working to protect and promote public health.   
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CHAPTER I 
INTRODUCTION 
Background 
Uterine fibroids (leiomyomas) affect 70% of U.S. women and often result in 
hysterectomy (Baird, 2003).  In 2007, 43% of hysterectomies performed in U.S. hospitals 
involved a diagnosis of uterine fibroids (Wechter, 2011).  U.S. hospitalizations for leiomyomas 
are expected to increase from 355,135 in 2007 to 437,874 in 2050, a 23% increase, with 
leiomyoma associated hysterectomies rising by 20% over the same time period (Wechter, 2011).   
In 2005, FDA cleared the da Vinci surgical system (Intuitive Surgical Inc., Sunnyvale, 
CA, USA), a robotic surgical assistant, and in October of 2008 International Classification of 
Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 17.42 was created for robotic 
assisted laparoscopy (Wright, 2013).  By 2010, 9.5% of U.S. hysterectomies were robotically 
assisted (Wright, 2013).   
Description of the Device 
The da Vinci system is composed of a robotic surgical tower and a surgical console 
(Chen, 2009).  The tower contains a camera arm, and two to three interactive arms (Chen, 2009).  
From within the console, the camera arm is controlled by a foot pedal while the interactive arms 
are manipulated by fingertip hand controls (Chen, 2009).  During surgery, the surgeon sits inside 
the console while directing the arms of the robot and interpreting a three dimensional display of 
the operative field (Chen, 2009).     
From the operator perspective the device offers several clear advantages over 
conventional laparoscopy.  Conventional laparoscopy requires surgeons to stand for the length of 
the procedure (as long as 4 hours) while working with long instruments (referred to by Schwartz, 
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2009 as “the ‘chopstick’ approach”) and fewer degrees of freedom (i.e., fewer possible types of 
motion; Chen, 2009).  The da Vinci system offers surgeons the opportunity to remain seated 
while working with two additional degrees of freedom and with more “intuitive” movements 
(Chen, 2009).  Furthermore, experience operating through the robot appears to attenuate the 
steep learning curve for laparoscopic skills among novice practitioners (Chen, 2009).  Finally, 
the device is able to remove the effect of surgeon hand tremors, scaling down motions and 
enabling surgeons to work at microvascular or even microscopic levels (Chen, 2009). 
Despite the benefits of the da Vinci system, robotic surgery presents its own learning 
curve and disadvantages (Chen, 2009).  Drawbacks of the da Vinci system include complete loss 
of tactile feedback, inability to simultaneously operate in the lower and upper abdomen, and 
reduced vaginal access (Chen, 2009).  The precision and power offered by the machine may be 
problematic when controlled by inexperienced hands.   
Learning Curve 
The learning curve for da Vinci surgery is widely recognized and described by published 
findings.  Lenihan et al. (2008) documented 113 consecutive da Vinci gynecological surgical 
procedures over a 22-month period beginning in 2005, at least 100 of which were 
hysterectomies.  Total operative times stabilized after 50 cases (Lenihan, 2008).  Schreuder  et al. 
(2010) reported that total operating time for robot-assisted laparoscopic radical hysterectomy fell 
from 9 hours to less than 4 hours in the first 14 cases performed by the same surgical team in 
2006-2008.  Woelk et al. (2013) included 325 cases in their study of Mayo Clinic robotic 
hysterectomies, and concluded that surgical proficiency occurs around 91 procedures, and that 36 
months of experience brings decreased operative time and shorter hospital stays (Woelk, 2013).   
3 
 
 
 
Currently the burden is on consumers to investigate surgeons’ training and experience 
with the robot before selecting and committing to a practitioner.  There are no uniform 
requirements for operating with the da Vinci system (Schwartz, 2009).  Guidelines differ from 
hospital to hospital and vary widely (Schwartz, 2009).     
Safety of Robotic Assisted Laparoscopic Hysterectomy (RALH) 
There were 280 cases reported for da Vinci gynecologic procedures in 2006-2012 in the 
Food and Drug Administration (FDA)’s Manufacturer and User Facility Device Experience 
(MAUDE) database, an adverse event reporting system (Manoucheri, 2014).  Hysterectomy was 
the most common procedure.  Twenty-six percent of reports involved injury, and 8.5% death.  
Planned hysterectomies were the setting for 15 fatalities.  Of the 15 hysterectomy fatalities, three 
involved iliac injury, one involved system shut down and aortic injury, and 11 resulted from 
bowel injury.  Overall, injury was attributed to user-related error (21%), technical system failure 
(14%), or was not directly related to the device (65%) (Manoucheri, 2014).   
Overall, patients undergoing any type of robotic assisted laparoscopic surgery are less 
likely to die, and experience shorter hospital stays than patients undergoing open surgery 
(Anderson, 2012).  However, no benefit is seen when comparing robotic-assisted laparoscopic 
surgery to non-robotic assisted laparoscopic procedures (Anderson, 2012).  This holds true for 
hysterectomy. 
When compared to conventional laparoscopic hysterectomy, total operating time for 
RALH is 20 to 70 minutes longer, a finding that is consistently statistically significant across 
studies (Ayala-Yanez, 2013).  Blood loss is consistently lower for RALH patients, and length of 
hospital stay is typically shorter by one day (Ayala-Yanez, 2013).  The precision offered by the 
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da Vinci Surgical System may benefit patients with larger uteruses as well as patients with pelvic 
adhesions from former surgeries (Ayala-Yanez, 2013).   
A Cochrane review published in 2012 examining two randomized controlled trials 
(RCTs) did not support robotic-assisted laparoscopic hysterectomy (RALH) in women with 
benign gynecological conditions, citing increased postoperative complications, operating times, 
and cost as concerns (Liu, 2012).  The reviewers also found that robotic assisted gynecological 
surgery is comparable to laparoscopic surgery with similar rates of conversions to open surgery 
(Liu, 2012).  
An earlier review of four observational studies found that RALH results in improved 
recovery, decreased blood loss and fewer conversions to open surgery when compared to 
conventional laparoscopic surgery (Weinberg, 2011).  It is suggested by the authors that the 
longer operating times seen in RALH (and reported in the Cochrane review) may be related to 
the learning curve for the device as well as uterine size and patient BMI (Weinberg, 2011).  The 
authors recommend DRS for hysterectomies involving larger uteruses and for surgeries of 
anticipated difficulty that may require conversion (Weinberg, 2011).   
In the 2010 and 2011 Nationwide Inpatient Sample (NIS), 5.1% of hysterectomies for 
benign conditions were robotically assisted (Rosero, 2013).  An analysis using propensity scores 
to match robotic to non-robotic cases based on patient characteristics revealed similar 
complication rates for conventional laparoscopic hysterectomies and RALH (Rosero, 2013).  
RALH patients required fewer blood transfusions but experienced more frequent postoperative 
pneumonia (Rosero, 2013).   
Relation to Present Study 
The da Vinci surgical system may be problematic when operated by inexperienced or inattentive 
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surgeons.  Twenty-one percent of reported injuries in FDA’s MAUDE database were user-
related for da Vinci gynecologic procedures in 2006-2012 (Manoucheri, 2014).  Since surgical 
proficiency for RALH occurs as late as 91 procedures (Woelk, 2013) and complications may be 
user-related (Manoucheri, 2014), it is thought that variations in rates of complications for RALH 
will be observed between hospitals, and that complication rates will differ with total number of 
RALHs and hospital teaching status.  The present study examines how inpatient complications 
relate to hospital characteristics for robotic and non-robotic laparoscopic hysterectomies. 
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CHAPTER II 
METHODS 
The Nationwide Inpatient Sample (NIS) 
This study examines complications for laparoscopic hysterectomy using discharge data 
from the 2009-2011 Nationwide Inpatient Sample (NIS), Healthcare Cost and Utilization Project 
(HCUP), Agency for Healthcare Research and Quality.  For each year, the NIS contains 
approximately 8 million discharge records from 1,000 hospitals in 46 states, representing a 20 
percent stratified sample of U.S. community hospitals.  The NIS includes hospitalizations 
regardless of payer, capturing uninsured patient stays (HCUP Nationwide Inpatient Sample). 
 Each NIS record represents a hospital stay.  Because records represent hospital stays and 
not individual patients, and there is no patient ID to match records upon, it is normally 
impossible to ensure that records represent unique patients.  Since this study examines 
hysterectomies and it is unlikely that a woman would receive more than one hysterectomy, the 
present study assumes that records represent individual patients.  Discharge records from women 
with a principal diagnosis of uterine fibroids and a primary procedure code for laparoscopic 
hysterectomy are included in this investigation. 
Variables 
 For 2009-2011, NIS provides up to 15 procedure codes and up to 25 diagnostic codes per 
record.   The first procedure code (variables PR1 for ICD-9-CM and PRCCS1 for Clinical 
Classification Software classification) typically represents the principal procedure.  The first 
diagnostic code (variables DX1 for ICD-9-CM and DXCCS1 for Clinical Classification Software 
classification) is the principal diagnosis.  Principal procedure was further categorized as robotic 
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or non-robotic.  Inpatient death is given by the variable DIED.  The percentage of patients who 
died for each procedure type was calculated.   
We assessed patient characteristics using variables for race (RACE), income quartile for 
patient zip code (ZIPINC_QRTL; classifies median household income for patient’s zip code for 
the corresponding year), primary expected payer (PAY1; public, private, other), admission type 
(ATYPE; emergency, elective, urgent), admission source (ASOURCE; emergency, other facility, 
routine, other), age (AGE; continuous), number of chronic conditions (NCHRON; continuous) 
and length of stay (LOS; continuous).  Detailed information for each variable can be found 
online (HCUP NIS, 2012). Percentages were calculated for all variables except for continuous 
variables.  Means were calculated for continuous variables. 
The HOSPID variable was used to link observations to a separate table containing 
hospital data (e.g., bed size, name, and location).  Characteristics were taken from the most 
recent data available for each hospital.  Hospital characteristics assessed included bed size 
(HOSP_BEDSIZE), teaching status (HOSP_TEACH), control/ownership of hospital 
(HOSP_CONTRL; government, private), location (HOSP_LOCATION; rural, urban), location 
combined with teaching status (HOSP_LOCTEACH; rural, urban teaching, urban non-teaching), 
multi-hospital system membership (HOSP_MHSMEMBER), and region (HOSP_REGION; 
Northeast, Midwest, South, West).  Percentages were calculated for all hospital related variables 
and compared with chi-square and Fisher’s exact tests. 
In the NIS, bed size is characterized as small, medium, or large and is a function of 
region, location (rural vs urban), and teaching status.  A rural hospital in the Northeast with 150 
beds is considered large while an urban, teaching hospital in the same region with the same 
number of beds is considered small.   
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Classification of hospitals as urban or rural is based upon Core Based Statistical Area 
(CBSA) codes as described in the NIS Description of Data Elements for HOSP_LOCATION 
(HCUP NIS, 2012).   
Data Management 
Data management and analysis were conducted in JMP and SAS 9.3 (SAS Institute Inc., 
Cary, NC, USA) using a combination of data steps and PROC SQL in the process displayed in 
figure 1.  Discharge records with a primary procedure code for laparoscopic hysterectomy (ICD-
9-CM 68.31, 68.41, 68.51, 68.61, or 68.71) were drawn from the NIS (2009-2011).  Records 
with a primary diagnosis Clinical Classification Software (CCS; Elixhauser, 2014) code of 
benign neoplasm of the uterus (CCS 46) were retained. A dichotomous variable was created to 
identify records containing at least one robotic-assisted laparoscopy code (ICD-9-CM 17.42) and 
this variable was used to create two data sets – one for robotic procedures and the other for non-
robotic procedures. 
In each data set, records with a CCS code of 238 ("Complications of surgical procedures 
or medical care") were flagged as having one or more complications.  Total number of 
complications falling under CCS 238 was calculated for each discharge, as well as complication 
rate (total number of complications divided by the total number of discharges) for each hospital.   
A hospital’s share of procedures was determined by dividing the total number of records 
from that hospital by the total number of procedures in the data set (robotic or non-robotic).  A 
hospital’s share of complications was calculated by dividing the total number of complications 
for that hospital by the total number or complications in the data set (robotic or non-robotic).   
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Figure 1 – Data management process 
 
Analysis 
Patient and hospital characteristics were assessed for all laparoscopic hysterectomies for 
benign gynecological conditions in the NIS from 2009 through 2011.  Percentiles for hospital 
complication rate were computed separately for non-robotic and robotic procedures using PROC 
UNIVARIATE.  Hospitals at or above the 75th percentile were compared to hospitals with 
10 
 
 
 
complication rates below the 75th percentile using PROC FREQ with the CHISQ option.  This 
analysis was conducted separately for robotic and non-robotic procedures.  Additionally, PROC 
CORR was carried out separately for robotic and non-robotic procedures to investigate the 
relationships between complication rate, total procedures, total complications, share of 
procedures, and share of complications. 
Sensitivity analyses were carried out to explore the effects of excluding hospitals with 
fewer than 5 or fewer than 10 procedures since total procedures for each hospital serves as the 
denominator for hospital complication rate.  A cutoff value of 5 or 10 did not make enough of a 
difference to affect p-values for Chi Square or Fischer's Exact, and overall patterns were the 
same.  A cutoff value of 5 was used for the final analysis since this raises the total number of 
hospitals included. 
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CHAPTER III 
RESULTS 
Of 65,922 laparoscopic hysterectomies in the 2009-2011 NIS, 19,196 (29.12%) were 
robotically assisted.  Benign neoplasm of uterus (CCS 46) was the principal diagnosis for 18,666 
of patients: 5,079 receiving robotic assisted laparoscopic hysterectomy and 13,587 undergoing 
conventional laparoscopic hysterectomy over the three year period.   
Half of RALH records included in the present study came from the 2011 NIS.  Number 
of RALH procedures for benign neoplasms of the uterus appearing in the NIS increased between 
2009 and 2011 (Figure 2).  Meanwhile the number of non-robotic laparoscopic hysterectomies 
for benign uterine neoplasms declined over the three year period (Figure 2). 
Figure 2 – Laparoscopic hysterectomies for uterine fibroids  
Nationwide Inpatient Sample (NIS), 2009-2011, Unweighted 
 
Patient Characteristics 
Characteristics of patients included in this study, as well as their hospitalization 
characteristics are presented in Table 1.  Mean age in years at admission was 46.34 for RALH 
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patients and 45.67 for non-robotic patients.  Length of stay was 1.44 and 1.49 days for RALH 
and non-robotic patients, respectively.  Number of chronic conditions per patient was 2.34 
(RALH) and 2.30 (non-robotic).   
Table 1 – Patient and hospitalization characteristics  
For women undergoing laparoscopic hysterectomy for uterine fibroids (NIS 2009-2011) 
 Non-robotic RALH Total 
 n=13,587 n=5,079 n=18,666 
 n % n % n % 
Admission source:       
Emergency department 43 0.32 16 0.32 59 0.32 
Other facility 71 0.52 6 0.12 77 0.41 
Routine, birth, and other 3,381 24.88 1,072 21.11 4,453 23.86 
Missing 10,092 74.28 3,985 78.46 14,077 75.42 
Admission type:       
Emergency 257 1.89 62 1.22 319 1.71 
Elective 9,938 73.14 3,936 77.50 13,874 74.33 
Urgent 955 7.03 314 6.18 1,269 6.80 
Other/Missing 2,437 17.94 767 15.10 3,204 17.16 
Primary payer:       
Private 10,771 79.27 4,108 80.88 14,879 79.71 
Medicare/Medicaid 1,737 12.78 661 13.01 2,398 12.85 
Other 1,060 7.80 300 5.91 1,360 7.29 
Missing/Invalid 19 0.14 10 0.20 29 0.16 
Race:       
White 7,018 51.65 2,595 51.09 9,613 51.50 
Black 2,710 19.95 999 19.67 3,709 19.87 
Hispanic 1,603 11.80 587 11.56 2,190 11.73 
Other 815 6.00 319 6.28 1,134 6.08 
Missing/Invalid 1,441 10.61 579 11.40 2,020 10.82 
Median household income national  
quartile for patient ZIP Code:       
0-25th percentile 2,773 20.41 946 18.63 3,719 19.92 
26th to 50th percentile (median) 2,890 21.27 999 19.67 3,889 20.83 
51st to 75th percentile 3,565 26.24 1,499 29.51 5,064 27.13 
76th to 100th percentile 4,057 29.86 1,579 31.09 5,636 30.19 
Missing 302 2.22 56 1.10 358 1.92 
Died during hospitalization 1 0.01 1 0.02 2 0.01 
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Hospital Characteristics 
Hospital characteristics for 5,079 discharges from 365 hospitals for RALH, and 13,587 
discharges from 1,111 hospitals for conventional laparoscopic hysterectomy are presented in 
Table 2.  RALH procedures were less likely to occur in small, rural, or non-teaching hospitals. 
Table 2 – Hospital characteristics 
Laparoscopic hysterectomies for uterine fibroids (NIS 2009-2011) 
 Non-robotic RALH 
 n=1,111 n=365 
 n % n % 
Bed size:         
Small 230 21 34 9 
Medium 330 30 93 25 
Large 536 48 230 63 
Missing 15 1 8 2 
Location:     
Urban 845 76 338 93 
Rural 251 23 19 5 
Missing 15 1 8 2 
Ownership:       
Government or private (collapsed category) 526 47 218 60 
Government, non-federal 91 8 17 5 
Private, voluntary 227 20 76 21 
Private, proprietary 156 14 41 11 
Private (collapsed category) 96 9 5 1 
Missing 15 1 8 2 
Region:     
Northeast 185 17 55 15 
Midwest 258 23 87 24 
South 427 38 141 39 
West 241 22 82 22 
Teaching status:       
Nonteaching 753 68 174 48 
Teaching 343 31 183 50 
Missing 15 1 8 2 
 
Complications 
Of 5,079 RALH patients with a primary diagnosis of benign neoplasm of the uterus, 338 
(6.65%) experienced complications of surgical procedures or medical care during their hospital 
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stay.  Of these, 35 (0.69%) experienced two or more of such complications.  Of 13,587 non-
robotic laparoscopic hysterectomy patients with the same diagnosis, 796 (5.86%) experienced 
complications, with 98 (0.72%) experiencing two or more complications. 
Complications are presented in Table 3.  Accidental laceration was the most common 
complication for both robotic and non-robotic procedures.  ‘Top ten’ complications did not differ 
between robotic and non-robotic cases, though order varied slightly.   
Table 3 - ‘Top ten’ complications1 
Laparoscopic hysterectomy for benign neoplasm of the uterus 
 
ICD-9-CM Diagnosis 
n (%) 
Robotic 
n=5,079 
Non-robotic 
n=13,587 
9982 : ACCIDENTAL OP LACERATION 154 ( 3.03% ) 335 ( 2.47% ) 
99811: HEMORR AS PROC CX (Begin 1996) 27 ( 0.53% ) 139 ( 1.02% ) 
9974 : SURG COMPLIC-GI TRACT (end 2011) 51 ( 1.00% ) 73 ( 0.54% ) 
78062: POSTPROCEDURAL FEVER (Begin 2008) 33 ( 0.65% ) 63 ( 0.46% ) 
9975 : SURG COMPL-URINARY TRACT 18 ( 0.35% ) 56 ( 0.41% ) 
99812: HEMATOMA PROC CX (Begin 1996) 18 ( 0.35% ) 53 ( 0.39% ) 
45829: OTHER IATROGENIC HYPOTENSION (Begin 2003) 12 ( 0.24% ) 39 ( 0.29% ) 
9971 : SURG COMPL-HEART 14 ( 0.28% ) 33 ( 0.24% ) 
99739: RESPIRATORY COMP NEC (Begin 2008) 15 ( 0.30% ) 31 ( 0.23% ) 
99859: OTH POSTOP INFECTION (Begin 1996) 11 ( 0.22% ) 18 ( 0.13% ) 
 
1Limited to 145 ICD-9-CM codes falling under clinical classification software (CCS) code 238 - 
Complications of surgical procedures or medical care 
 
Complications and Hospital Characteristics 
RALH discharges with complications (CCS 238; n=338) represented 169 (46%) 
hospitals.  Non-robotic discharges with complications (n=796) represented 444 (40%) hospitals.   
After restricting analysis to hospitals with 5 or more procedures, the 75th percentile for 
hospital complication rate was 12.5% for RALH (n=226 hospitals) and 11.1% for non-robotic 
procedures (n=633 hospitals).   
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For RALH (table 4), there was a significant association between location (urban/rural) 
and whether or not a hospital fell into the higher complication group or lower complication 
group (Fisher's Exact  two-sided p < .05).  Most rural hospitals fell into the highest quartile for 
hospital complication rate.  This was also observed for the variable location/teaching variable 
which combines location (urban/rural) and teaching status (chi-square = 8.60, p < 0.05).  For 
non-robotic procedures (table 5), there was a significant association between teaching status and 
high/low complication rate (chi-square = 8.34, p < 0.01), and the combined location/teaching 
status variable and high/low complication rate (chi-square = 6.8167, p < 0.05).  More teaching 
hospitals than expected fell into the highest quartile for hospital complication rate. 
Both hospitals with patient deaths (n=2) had complication rates below the 75th percentile 
and at least 30 procedures.  One patient experienced a cardiac complication that was included in 
CCS 238 and thus included in this analysis. 
Variable correlations 
Before restricting the analysis to hospitals with 5 or more procedures, complication rate 
for non-robotic laparoscopic hysterectomy was related to total number of procedures performed 
(r= -.08, r2=.01, p<.01, n=1,111).  Total number of procedures performed was not significantly 
related to hospital complication rate for robotic surgery (r= -.08, r2=.01, p=.15, n=365).  This 
held true after restricting the analysis to hospitals with 5 or more procedures (robotic: r= -.09657, 
r2=.00933, p=.1479, n=226; non-robotic: r= -.08096, r2=.00655, p=.0417, n=633).  When 
analysis was restricted to hospitals with 10 or more procedures, the relationship between 
complication rate and total procedures performed was attenuated for non-robotic hospitals and 
strengthened for robotic hospitals (robotic: r= -.15819, r2=.025, p=.0592, n=143; non-robotic: r= 
-.06967, r2=.00485, p=.1643, n=400).  
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Table 4 - Characteristics for hospitals with at least 5 procedures 
Robotic assisted laparoscopic hysterectomy (RALH) (n=226) 
 
 Complication Rate 
Variable 
n (%)  
Lowest 
75% 
n = 169 
Highest 
25% 
n = 57 
Bed size of hospital1 Missing 3 ( 1.8)  
 1: Small 15 ( 8.9) 4 ( 7.0) 
 2: Medium 45 (26.6) 15 (26.3) 
 3: Large 106 (62.7) 38 (66.7) 
Control/ownership of hospital Missing 3 ( 1.8)  
 1: Government, non-federal (public) 12 ( 7.1) 4 ( 7.0) 
 2: Private, not-for-profit (voluntary) 124 (73.4) 45 (78.9) 
 3: Private, investor-owned (proprietary) 30 (17.8) 8 (14.0) 
Location (urban/rural) of hospital** Missing 3 ( 1.8)  
 0: Rural 2 ( 1.2) 5 ( 8.8) 
 1: Urban 164 (97.0) 52 (91.2) 
Location/teaching status of 
hospital*** 
Missing 3 ( 1.8)  
 1: Rural 2 ( 1.2) 5 ( 8.8) 
 2: Urban nonteaching 83 (49.1) 23 (40.4) 
 3: Urban teaching 81 (47.9) 29 (50.9) 
Multi-hospital system membership Missing 16 ( 9.5) 6 (10.5) 
 0: Hospital is not a member of a multi-hospital 
system 
39 (23.1) 14 (24.6) 
 1: Hospital is a member of a multi-hospital system 114 (67.5) 37 (64.9) 
Region of hospital 1: Northeast 22 (13.0) 11 (19.3) 
 2: Midwest 37 (21.9) 14 (24.6) 
 3: South 69 (40.8) 17 (29.8) 
 4: West 41 (24.3) 15 (26.3) 
Teaching status of hospital Missing 3 ( 1.8)  
 0: Nonteaching 85 (50.3) 28 (49.1) 
 1: Teaching 81 (47.9) 29 (50.9) 
 
1Bedsize is a function of region, location (rural vs urban), and teaching status.  For more information: 
https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp 
 
**Fisher’s Exact Test Two-sided p < .05 
***Chi-Square p < .05 
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Table 5 - Characteristics for hospitals with at least 5 procedures 
Conventional (non-robotic) laparoscopic hysterectomy (n=633) 
 
 Complication Rate 
Variable 
n (%)  
Lowest 
75% 
n = 472 
Highest 
25% 
n = 161 
Bed size of hospital1 Missing 4 ( 0.8) 3 ( 1.9) 
 1: Small 70 (14.8) 23 (14.3) 
 2: Medium 132 (28.0) 56 (34.8) 
 3: Large 266 (56.4) 79 (49.1) 
Control/ownership of hospital Missing 4 ( 0.8) 3 ( 1.9) 
 1: Government, non-federal (public) 51 (10.8) 23 (14.3) 
 2: Private, not-for-profit (voluntary) 347 (73.5) 110 (68.3) 
 3: Private, investor-owned (proprietary) 70 (14.8) 25 (15.5) 
Location (urban/rural) of hospital Missing 4 ( 0.8) 3 ( 1.9) 
 0: Rural 59 (12.5) 20 (12.4) 
 1: Urban 409 (86.7) 138 (85.7) 
Location/teaching status of 
hospital*** 
Missing 4 ( 0.8) 3 ( 1.9) 
 1: Rural 59 (12.5) 20 (12.4) 
 2: Urban nonteaching 239 (50.6) 63 (39.1) 
 3: Urban teaching 170 (36.0) 75 (46.6) 
Multi-hospital system membership Missing 47 (10.0) 20 (12.4) 
 0: Hospital is not a member of a multi-hospital 
system 
123 (26.1) 43 (26.7) 
 1: Hospital is a member of a multi-hospital system 302 (64.0) 98 (60.9) 
Region of hospital 1: Northeast 76 (16.1) 30 (18.6) 
 2: Midwest 89 (18.9) 36 (22.4) 
 3: South 184 (39.0) 59 (36.6) 
 4: West 123 (26.1) 36 (22.4) 
Teaching status of hospital*** Missing 4 ( 0.8) 3 ( 1.9) 
 0: Nonteaching 295 (62.5) 79 (49.1) 
 1: Teaching 173 (36.7) 79 (49.1) 
 
1Bedsize is a function of region, location (rural vs urban), and teaching status.  For more information: 
https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp 
 
***Chi-Square p < .05 
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CHAPTER IV 
DISCUSSION 
This is the first study that we are aware of that examines hospital characteristics as they 
relate to complication rates for RALH.  It includes three years of data from the largest source of 
all-payer inpatient data in the U.S. (HCUP NIS, 2012).   
In the United States, robotic-assisted laparoscopic hysterectomy (RALH) has been on the 
rise for benign uterine conditions since the da Vinci system received regulatory clearance in 
2005 (Rosero, 2013; Wright, 2013).  Number of RALH procedures for benign neoplasms of the 
uterus appearing in the NIS increased between 2009 and 2011 while the number of non-robotic 
laparoscopic hysterectomies declined and the total number of hysterectomies increased, 
suggesting that RALH may be in the process of replacing conventional laparoscopic 
hysterectomy (Figure 2). 
Complications 
Accidental laceration was the most common complication for RALH, followed by 
gastrointestinal tract complications, perhaps supporting Manoucheri’s (2014) MAUDE finding of 
iliac, aortic, and bowel injuries.  Blood loss is consistently lower for RALH patients (Ayala-
Yanez, 2013; Weinberg, 2011; Rosero, 2013) and the present study found that hemorrhage was 
lower for robotic procedures compared to non-robotic procedures. 
For RALH, there was a significant association between location (urban/rural) and 
whether or not a hospital fell into the higher complication group or lower complication group, 
with rural hospitals more likely to fall into the higher complication group.  Rural status may 
indicate lower number of surgeries and therefore a lower denominator which could make 
complication rate appear inflated, however, hospitals with fewer than 5 or 10 procedures were 
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removed and the analysis was repeated with the same results.  Perhaps rural hospitals are simply 
less experienced with robotic surgery due to lack of resources or lower number of eligible 
patients.  Lower number of patients undergoing RALH might also be indicative of lower socio-
economic status since the surgery is known to be more expensive than conventional laparoscopic 
surgery.   
For non-robotic procedures, there was a significant association between teaching status 
and high/low complication rate, with more teaching hospitals than expected falling into the high 
complication rate group.  The chi-square for teaching status and high/low complication rate for 
robotic surgery was not significant.  Perhaps teaching status is less relevant for robotic surgery 
because most practitioners are new to it since it is a fairly recent development.  However, due to 
the nature of the chi-square test, we are unable to tell whether or not the significant result for the 
location/teaching status variable is simply due to the urban/rural breakdown, or whether dividing 
urban hospitals into teaching and non-teaching revealed something that the teaching/non-
teaching variable did not.  A next step would be to repeat the test for teaching status and 
high/low complication rate, excluding rural hospitals. 
Learning Curve 
In general, it appears that the more laparoscopic hysterectomies a hospital performed, the 
lower its complication rate, as demonstrated by a negative Pearson’s r in all scenarios that we 
analyzed.  When analysis was restricted to hospitals with 10 or more procedures, the relationship 
between complication rate and total procedures performed was strengthened for robotic surgery.  
However, for RALH, Pearson’s r was always low, and non-significant.   
These findings might be explained by the fact that a noticeable or significant drop in 
complication rate might not occur until a hospital has reached 50 or even 90 procedures or 36 
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months of experience (Lenihan, 2008; Woelk, 2013).  Only five of the hospitals included in the 
RALH analysis totaled at least 90 procedures during the 36 month period included in this study.  
All five hospitals totaling at least 90 procedures had complication rates below the 75th percentile, 
and were large, private, urban hospitals, three teaching and two non-teaching. Four were 
members of a multi-hospital system and one was missing this information in the database.  
Twenty of 365 hospitals totaled 50 or more RALH procedures, the learning curve suggested by 
Lenihan (2008).  After additional years of NIS data are released and hospitals become more 
experienced with RALH, further analysis may be possible. 
Limitations 
The present analysis only includes a three year period and we are unable to assess when 
each hospital first began operating with the da Vinci.  The learning curve for surgical proficiency 
is thought to require as many as 91 procedures and 36 months of experience (Woelk, 2013).  
Only five of the 365 hospitals totaled at least 90 procedures during the 36 month period included 
in this study.   
Data were analyzed without controlling for patient characteristics, such as primary payer, 
income, or admission source, which may be related to hospital selection and patient outcome.  It 
is unknown whether exploring such factors would reveal or dispel any pattern (i.e., confounding 
or effect modification).  Furthermore, only women with a principal diagnosis of uterine fibroids 
were included in this study, and results may not be generalizable to all RALH surgeries. 
CCS 238 (“Complications of surgical procedures or medical care”) captures 145 ICD-9-
CM codes.  Complications that did not fall under CCS 238 were not counted.  Death was also not 
included in complication counts or rates.   
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Finally, hospitals served as the unit of analysis for our comparisons.  A hospital’s 
experience with RALH may actually be a marker of an individual surgeon’s experience with the 
procedure.  In this case our results could be interpreted as “rural surgeons” and “surgeons 
operating in teaching hospitals” may have higher than expected complication rates for RALH 
compared to conventional laparoscopic hysterectomy.  The NIS includes a variable that identifies 
unique physicians.  Assessing complication rate by physician ID might reveal a stronger 
correlation between number of procedures performed and complication rate.  However, 
physician ID may not necessarily represent the operating surgeon. 
Conclusion 
This study offers some evidence that hospital complication rate for RALH for uterine 
fibroids could be related to rural location and/or positive teaching status.  Further investigation 
exploring variables that may be related to hospital selection and patient outcome (e.g., primary 
payer, emergency admission) might reveal confounding and/or effect modification and thereby 
attenuate or strengthen these findings.   
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